SCHEMBL18625752

SCHEMBL18625752

C=CC1CN2CCC1C[C@@H]2C(Oc1cc(C)c2ccccc2n1)c1ccnc2ccc(OC)cc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.68
CYP2D6 P10635 6/20 0.67
ALDH1A1 P00352 5/20 0.67
ABCB1 P08183 4/20 0.67
SLC22A1 O15245 3/20 0.67
ABCB11 O95342 3/20 0.67
ADRA2A P08913 3/20 0.67
SLC6A4 P31645 3/20 0.67
OPRM1 P35372 3/20 0.67
SCN1A P35498 3/20 0.67
KCNH2 Q12809 3/20 0.67
SCN2A Q99250 3/20 0.67
SCN3A Q9NY46 3/20 0.67
CYP3A4 P08684 3/20 0.67
HSD17B10 Q99714 3/20 0.67
SLC22A2 O15244 2/20 0.67
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
THRB P10828 1/20 0.67
ABCC4 O15439 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16234447 1.00 KDM4E (0.68) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
SCHEMBL16232487 0.92 CYP2D6 (0.58) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
Quinidine SCHEMBL28976265 0.90 CYP2D6 (0.77) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
Quinine SCHEMBL16243379 0.90 CYP2D6 (0.77) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
Quinidine SCHEMBL28976194 0.90 CYP2D6 (0.77) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
SCHEMBL57373 0.87 CYP2D6 (0.66) KDM4ECYP2D6ALDH1A1ADRA2ASLC6A4
SCHEMBL3957529 0.87 CYP2D6 (0.66) KDM4ECYP2D6ALDH1A1ADRA2ASLC6A4
SCHEMBL15906047 0.87 CYP2D6 (0.66) KDM4ECYP2D6ALDH1A1ADRA2ASLC6A4
SCHEMBL29830803 0.87 KDM4E (0.72) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
SCHEMBL23651303 0.87 KDM4E (0.69) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9593071-B2 Process for the preparation of gamma amino acids and intermediates used in said process ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) 2017-03-14 US disclosed